Back to search

France· FR:64564024

VELTASSA 8,4 g, poudre pour suspension buvable

A medicinal product containing patiromère sorbitex calcique, registered in France by VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVELTASSA 8,4 g, poudre pour suspensio…ATC—REGISTER NO.FR:64564024PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PATIROMÈRE SORBITEX CALCIQUE
Manufacturer
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930124048
    30 sachet(s) papier polyester polyéthylène aluminium
    EUR 189.63

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e509b4cc-98e8-4e2b-a0de-3d0a89899488
GET /v1/drugs/e509b4cc-98e8-4e2b-a0de-3d0a89899488?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64564024",
  "date_amm": "2017-07-19",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/17/1179",
  "substance": "PATIROMÈRE SORBITEX CALCIQUE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour suspension buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about patiromère sorbitex calcique.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.